OYST
Oyster Point Pharma, Inc. Common Stock
OYST
OYST
Delisted
OYST was delisted on the 30th of December, 2022.
66 hedge funds and large institutions have $380M invested in Oyster Point Pharma, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
-6
Holders Change %
-8.33%
% of All Funds
1.34%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
7
Increased
21
Reduced
20
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$2.69M |
2 |
SCM
Sio Capital Management
New York
|
+$2.23M |
3 |
BlackRock
New York
|
+$1.43M |
4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$1.38M |
5 |
Charles Schwab
San Francisco,
California
|
+$1.14M |